Keyphrases
SH-SY5Y Cells
100%
Neuroprotective Effect
100%
MPP+
100%
CB2 Receptor
100%
JZL184
100%
Monoacylglycerol Lipase Inhibition
57%
Cell Survival
42%
Endocannabinoid System
28%
Mouse Model
14%
In Vitro Model
14%
Receptor Antagonist
14%
Parkinson's Disease
14%
Neuroprotection
14%
Nigrostriatal Pathway
14%
Parkinson's Disease Model
14%
Mechanism of Action
14%
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
14%
Cannabinoid Receptor 1 (CB1R)
14%
Neuroprotective Mechanisms
14%
Iodide
14%
In Vitro Cell Models
14%
Cannabinoid Receptor 2
14%
Rimonabant
14%
CB1 Receptor Antagonist
14%
1-methyl-4-phenylpyridinium
14%
Mechanisms of Neuroprotection
14%
AM630
14%
CB2 Receptor Agonist
14%
JWH133
14%
Medicine and Dentistry
Neuroprotective Agent
100%
SH-SY5Y
100%
Cannabinoid 2 Receptor
100%
4 [bis(1,3 Benzodioxol 5 Yl)hydroxymethyl] 1 Piperidinecarboxylic Acid 4 Nitrophenyl Ester
100%
MPP+
100%
Acylglycerol Lipase
57%
Cell Survival
42%
In Vitro
28%
Neuroprotection
28%
Parkinson's Disease
28%
Endocannabinoid System
28%
Receptor Antagonist
14%
Cellular Model
14%
Cannabinoid 1 Receptor
14%
6 Iodo 3 (4 Methoxybenzoyl) 2 Methyl 1 (2 Morpholinoethyl)indole
14%
1 Deoxy 3 (1,1 Dimethylbutyl) Delta8 Tetrahydrocannabinol
14%
Rimonabant
14%
Cannabinoid 1 Receptor Antagonist
14%
Cannabinoid 2 Receptor Agonist
14%
1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine
14%
1 Methyl 4 Phenylpyridinium
14%
SH-SY5Y Cell Line
14%
Neuroscience
Neuroprotective Agent
100%
MPP+
100%
Cannabinoid 2 Receptor
100%
Acylglycerol Lipase
66%
Cell Survival
50%
In Vitro
33%
Parkinson's Disease
33%
Neuroprotection
33%
Endocannabinoid System
33%
Dopaminergic
16%
Cell Line
16%
Receptor Antagonist
16%
Tetrahydropyridine
16%
Cannabinoid 1 Receptor
16%
Nigrostriatal Pathway
16%
CB1 Receptor Antagonists
16%
Rimonabant
16%
CB2 Receptor Agonist
16%
Pharmacology, Toxicology and Pharmaceutical Science
Neuroprotective Agent
100%
4 [bis(1,3 Benzodioxol 5 Yl)hydroxymethyl] 1 Piperidinecarboxylic Acid 4 Nitrophenyl Ester
100%
Cannabinoid 2 Receptor
100%
Acylglycerol Lipase
57%
Parkinson's Disease
28%
Neuroprotection
28%
Endocannabinoid System
28%
Mouse Model
14%
Dopamine Receptor Stimulating Agent
14%
Receptor Antagonist
14%
1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine
14%
Cannabinoid 1 Receptor
14%
Rimonabant
14%
1 Deoxy 3 (1,1 Dimethylbutyl) Delta8 Tetrahydrocannabinol
14%
1 Methyl 4 Phenylpyridinium
14%
Cannabinoid 2 Receptor Agonist
14%
Cannabinoid 1 Receptor Antagonist
14%
6 Iodo 3 (4 Methoxybenzoyl) 2 Methyl 1 (2 Morpholinoethyl)indole
14%
Biochemistry, Genetics and Molecular Biology
Monoacylglycerol Lipase
100%
Cell Survival
75%
Receptor Antagonist
50%
Endocannabinoid System
50%
Mouse Model
25%
Animal Model
25%
Receptor Agonists
25%
Dopaminergic
25%
Cannabinoid Receptor
25%
Rimonabant
25%